Head and Neck Cancer Supportive Care Protocol

OncologyLimited Evidence
5
supplements
2
Primary
3
Supporting
1
Grade A
37
Studies

Primary Stack

Core supplements with strongest evidence
10-30g daily during radiation treatment

May help reduce mucositis severity from radiation

10 studies600 participants
2-3g EPA+DHA daily

Anti-inflammatory; supports weight maintenance during treatment

6 studies300 participants

Supporting Stack

Additional supplements for enhanced results
1.2-1.5g/kg/day total protein

Critical for maintaining muscle mass; swallowing difficulties limit intake

12 studies800 participants
2000-4000 IU daily

Supports immune function; often deficient

5 studies250 participants
15-30mg daily

Supports wound healing; taste changes common

↓Mucositis Symptoms
4 studies200 participants

How This Protocol Works

Simple Explanation

Head and neck cancers include cancers of the mouth, throat, voice box, sinuses, and salivary glands. Treatment often significantly impacts eating, swallowing, and speaking.

TYPES:

•Oral cavity cancer (mouth, tongue, gums)
•Oropharyngeal cancer (tonsils, base of tongue) - often HPV-related
•Laryngeal cancer (voice box)
•Hypopharyngeal cancer (lower throat)
•Nasopharyngeal cancer
•Salivary gland cancer

CRITICAL: Head and neck cancer requires comprehensive oncological care. This protocol is SUPPORTIVE ONLY.

TREATMENT CHALLENGES:

•Mucositis: Painful mouth/throat sores from radiation
•Dysphagia: Difficulty swallowing
•Xerostomia: Dry mouth (can be permanent)
•Taste changes: Often severe
•Weight loss: Very common
•Feeding tube: Often needed during treatment

NUTRITIONAL PRIORITIES:

•Maintain weight and muscle mass
•Adequate protein intake
•Manage swallowing difficulties
•Address taste changes

* Glutamine may help reduce mucositis severity.

* Protein intake is critical but challenging.

* Discuss all supplements with oncology team.

Expected timeline: Treatment effects (mucositis, dysphagia) typically peak mid-treatment and improve weeks to months after.

Clinical Perspective

Head and Neck Cancer: Squamous cell carcinoma most common. Risk factors: tobacco, alcohol, HPV (oropharyngeal). Treatment: surgery, radiation +/- chemo depending on stage/site. HPV+ oropharyngeal has better prognosis.

CRITICAL: Nutrition major challenge - mucositis, dysphagia, xerostomia, taste changes lead to significant weight loss. PEG tube often needed. Glutamine has evidence for mucositis reduction. Protein supplementation essential. Discuss supplements with oncology - timing around treatment important. Oncology dietitian essential.

* Glutamine (B-grade): Mucositis. Meta-analysis: (PMID: 22089180). 10-30g daily during RT.

* Omega-3 (C-grade): Weight/inflammation. Systematic review: (PMID: 27840029). 2-3g EPA+DHA daily.

* Protein (A-grade): Muscle maintenance. Guidelines: (PMID: 28698222). 1.2-1.5g/kg/day.

* Vitamin D (C-grade): Immune support. Systematic review: (PMID: 28750270). 2000-4000 IU daily.

* Zinc (C-grade): Taste/healing. Review: (PMID: 26845419). 15-30mg daily.

Protocol notes: Mucositis: glutamine, good oral care, pain management. PEG tube: often placed prophylactically; allows nutrition during severe mucositis/dysphagia. Xerostomia: can be permanent; artificial saliva, sipping water, pilocarpine. Taste changes: often severe; zinc may help; patience needed. Weight: weekly monitoring; early intervention. Swallowing: speech/swallowing therapy essential. HPV: vaccination prevents HPV+ cancers. Smoking cessation: critical for outcomes.